GK
MEDP icon

Graney & King’s Medpace MEDP Stock Holding History

Graney & King’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Hold
20
– – ﹤0.01% 250
2026
Q1 		$9.6K Hold
20
– – 0.01% 240
2025
Q4 		$11.2K Hold
20
– – 0.01% 230
2025
Q3 		$10.3K Buy
+20
New +$8.73K 0.01% 230

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Graney & King's MEDP Position: Q2 2026 in Review

Graney & King held its Medpace (MEDP) position steady in Q2 2026 at 20 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #250.

Graney & King first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.2K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Graney & King held 20 shares of Medpace worth $10.6K as of Q2 2026.
  • Graney & King left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Graney & King's portfolio in Q2 2026, its #250 holding.
  • Graney & King first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Graney & King's Medpace position peaked at $11.2K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.